Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Foghorn Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for FHTX.
You can purchase shares of Foghorn Therapeutics (NASDAQ:FHTX) through any online brokerage.
Other companies in Foghorn Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), Monopar Therapeutics (NASDAQ:MNPR), Neurogene (NASDAQ:NGNE), Abeona Therapeutics (NASDAQ:ABEO) and Design Therapeutics (NASDAQ:DSGN).
Foghorn Therapeutics has a consensus price target of $13.60.
The stock price for Foghorn Therapeutics (NASDAQ: FHTX) is $4.36 last updated April 25, 2025 at 4:02 PM EDT.
There are no upcoming dividends for Foghorn Therapeutics.
Foghorn Therapeutics’s Q1 earnings are confirmed for Friday, May 9, 2025.
There is no upcoming split for Foghorn Therapeutics.
Foghorn Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.